AIM

Conviction 4Scan · Fri, Jun 26, 2026

AIM$0.3108-12.55%

ResistanceSupportVol 14

Vol MA14 10.16M

Mar 27Apr 15May 4May 20Jun 9Jun 26

WSB mentions · 24h changelatest +400.00%· 5 mentions

Mar 27Apr 15May 4May 20Jun 9Jun 26

AIM ImmunoTech Inc.Biological Products, (No Diagnostic Substances)www.aimimmuno.com ↗

Price0.3108

Change-12.55%

Gap-4.28%

Rel volume0.12×

Avg volume30.07M

Avg $ vol22.55M

SMA 200.4779

SMA 500.4443

SMA 2001.24

Price vs 50-30.05%

Price vs 200-74.92%

MA stackbearish

50/200 cross—

Supertrendup · 0.3092

RSI (14)40

MACD hist-0.01

MACD cross—

Stoch %K / %D0 / 5

ADX (14)33

+DI / −DI31 / 20

RSI divergence—

MACD divergence—

ATR %+30.87%

ADR %20.13%

52w high9.57

52w low0.2327

From 52w high-96.75%

Above 52w low+33.56%

New 52w highNo

SqueezeOff

Bollinger width132.57%

%B0.24

Donchian pos0.17%

Donchian high1.25

Donchian low0.3092

AVWAP (52w high)0.6741

vs AVWAP high-53.89%

AVWAP (52w low)0.5744

vs AVWAP low-45.89%

OBV trendUp

Chaikin MF (20)-0.10

Today vs 20d0.12×

Avg vol (14d)10.16M

Avg vol (20d)30.07M

Avg $ vol (20d)22.55M

Market cap—

RS 3m (vs SPY)-70.11%

RS 6m (vs SPY)-81.84%

RS line new highNo

Trend template1/8

Technical rank3.4

1 week-18.19%

1 month-22.51%

3 months-55.05%

6 months-76.09%

1 year-96.55%

YTD-73.88%

P/E-0.37

P/B2.41

P/S58.19

P/FCF-0.47

EPS-8.62

Div yield—

ROE-656.85%

ROA-162.59%

Debt/Eq1.98

Current1.01

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-48.24%

EPS growth19.41%

Price target5.25

Target upside1393.17%

Analyst ratingBuy

Institutional0.70%

Ent. value3.52M

Revenue22K

Net income-3.02M

Gross profit—

Free cash flow-10.97M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNYSE

Shares out24.33M

Employees21

ListedThu, Nov 2, 1995

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank3.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.9715

Support0.2255

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AIM

All disclosures →

No recent disclosed trades by Congress in AIM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AIM

No recent insider (Form 4) filings in AIM. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in AIM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.